Business Description
Encompass Health Corp
NAICS : 621498
SIC : 8093
ISIN : US29261A1007
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 1.78 | |||||
Debt-to-EBITDA | 2.86 | |||||
Interest Coverage | 5.1 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.55 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.9 | |||||
3-Year EBITDA Growth Rate | 10.9 | |||||
3-Year EPS without NRI Growth Rate | 22.1 | |||||
3-Year FCF Growth Rate | -4.2 | |||||
3-Year Book Growth Rate | 0.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12.77 | |||||
Future 3-5Y Total Revenue Growth Rate | 8.81 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.28 | |||||
Quick Ratio | 1.28 | |||||
Cash Ratio | 0.11 | |||||
Days Sales Outstanding | 41.53 | |||||
Days Payable | 255.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -18.8 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 4.67 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 95.45 | |||||
Operating Margin % | 15.24 | |||||
Net Margin % | 7.33 | |||||
FCF Margin % | 5.67 | |||||
ROE % | 23.86 | |||||
ROA % | 6 | |||||
ROIC % | 10.83 | |||||
ROC (Joel Greenblatt) % | 21.81 | |||||
ROCE % | 14.33 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.39 | |||||
PE Ratio without NRI | 21.35 | |||||
Shiller PE Ratio | 22.67 | |||||
Price-to-Owner-Earnings | 33.64 | |||||
PEG Ratio | 8.9 | |||||
PS Ratio | 1.64 | |||||
PB Ratio | 4.73 | |||||
Price-to-Tangible-Book | 88.28 | |||||
Price-to-Free-Cash-Flow | 29.32 | |||||
Price-to-Operating-Cash-Flow | 9.25 | |||||
EV-to-EBIT | 14.18 | |||||
EV-to-EBITDA | 10.39 | |||||
EV-to-Revenue | 2.22 | |||||
EV-to-FCF | 39.77 | |||||
Price-to-Projected-FCF | 2.07 | |||||
Price-to-DCF (Earnings Based) | 1.74 | |||||
Price-to-DCF (FCF Based) | 2.35 | |||||
Price-to-Median-PS-Value | 1.32 | |||||
Price-to-Graham-Number | 9.16 | |||||
Earnings Yield (Greenblatt) % | 7.05 | |||||
FCF Yield % | 3.44 | |||||
Forward Rate of Return (Yacktman) % | 4.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Encompass Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 84,128.577 | ||
EPS (TTM) (MXN) | 60.84 | ||
Beta | 0.01 | ||
Volatility % | 0.32 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0 | ||
20-Day SMA (MXN) | 1280.07517 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (MXN) | 1280.07517 - 1280.07517 | ||
Shares Outstanding (Mil) | 100.14 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Encompass Health Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Encompass Health Corp Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Encompass Health Corp Frequently Asked Questions
What is Encompass Health Corp(MEX:EHC)'s stock price today?
When is next earnings date of Encompass Health Corp(MEX:EHC)?
Does Encompass Health Corp(MEX:EHC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |